Tony Wood
Fortuna: 59 764 $ al 30/06/2026
Fortuna: 59 764 $ al 30/06/2026
Tony Wood currently works at The Rosalind Franklin Institute, as Director and GSK Plc, as Chief Scientific Officer from 2022.
Dr. Wood also formerly worked at Pfizer Ltd., as Senior VP-Medicinal Science & Technology.
Dr. Wood received his undergraduate degree and doctorate degree from The University of Newcastle.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GSK PLC 0 % | 10/07/2026 | 2.273 ( 0 % ) | 59 764 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GSK PLC | Director Técnico/Científico/I+D | 19/01/2022 |
The Rosalind Franklin Institute
The Rosalind Franklin Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and technology development in life sciences | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
The University of Newcastle
The University of Newcastle Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rosalind Franklin Institute
The Rosalind Franklin Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and technology development in life sciences | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.